Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,244 | 259 | 97.7% |
| Education | $99.00 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $747.48 | 54 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $734.56 | 35 | $0 (2024) |
| UCB, Inc. | $677.30 | 48 | $0 (2024) |
| Amgen Inc. | $532.48 | 40 | $0 (2024) |
| Janssen Biotech, Inc. | $506.25 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $369.64 | 18 | $0 (2024) |
| PFIZER INC. | $215.81 | 11 | $0 (2024) |
| United Therapeutics Corporation | $102.93 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $83.78 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $82.42 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,551 | 75 | ABBVIE INC. ($339.14) |
| 2023 | $1,335 | 69 | Novartis Pharmaceuticals Corporation ($253.99) |
| 2022 | $598.67 | 40 | Amgen Inc. ($195.38) |
| 2021 | $858.47 | 76 | AbbVie Inc. ($224.77) |
All Payment Transactions
260 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Immunology | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: Immunology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Immunology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $53.91 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $32.72 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 299 | 592 | $101,930 | $32,828 |
| 2022 | 4 | 267 | 537 | $92,636 | $29,940 |
| 2021 | 6 | 399 | 719 | $85,967 | $33,999 |
| 2020 | 7 | 465 | 633 | $69,288 | $22,147 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 125 | 304 | $43,196 | $16,488 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 180 | $35,880 | $10,046 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,763 | $2,283 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 31 | 31 | $7,743 | $2,202 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 24 | $3,552 | $962.59 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 22 | $1,796 | $847.60 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 130 | 347 | $50,662 | $19,432 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 94 | $24,440 | $5,976 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $7,833 | $1,605 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 21 | 21 | $5,233 | $1,448 | 27.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 38 | 38 | $2,964 | $909.76 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 14 | 16 | $1,504 | $569.45 | 37.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 178 | 464 | $67,744 | $28,750 | 42.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 37 | 43 | $4,042 | $1,721 | 42.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 22 | 22 | $5,346 | $1,651 | 30.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 75 | 80 | $6,240 | $1,196 | 19.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 13 | 13 | $1,625 | $477.05 | 29.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Facility | 2021 | 74 | 97 | $970.00 | $204.00 | 21.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 171 | 288 | $43,872 | $13,273 | 30.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 119 | 140 | $10,920 | $4,644 | 42.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 48 | 54 | $5,908 | $1,589 | 26.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 14 | 14 | $4,572 | $1,188 | 26.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 17 | 18 | $2,250 | $887.68 | 39.5% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Facility | 2020 | 25 | 36 | $936.00 | $367.14 | 39.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Facility | 2020 | 71 | 83 | $830.00 | $196.80 | 23.7% |
About Ashley Goble, APRN
Ashley Goble, APRN is a Family healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2019. The National Provider Identifier (NPI) number assigned to this provider is 1508323163.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Goble, APRN has received a total of $4,343 in payments from pharmaceutical and medical device companies, with $1,551 received in 2024. These payments were reported across 260 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,244).
As a Medicare-enrolled provider, Goble has provided services to 1,430 Medicare beneficiaries, totaling 2,481 services with total Medicare billing of $118,914. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Ashland, KY
- Active Since 03/01/2019
- Last Updated 05/30/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1508323163
Products in Payments
- RINVOQ (Biological) $626.04
- Cimzia (Drug) $606.60
- COSENTYX (Drug) $544.24
- Enbrel (Biological) $408.86
- SAPHNELO (Biological) $369.64
- TREMFYA (Drug) $320.72
- XELJANZ (Drug) $199.40
- COSENTYX (Biological) $190.32
- REMICADE (Biological) $185.53
- SKYRIZI (Biological) $89.94
- ORENCIA (Biological) $82.42
- Bimzelx (Biological) $70.70
- Otezla (Drug) $59.14
- EVENITY (Biological) $48.21
- OFEV (Drug) $44.40
- KINERET (Drug) $44.31
- ACTHAR (Biological) $44.26
- TALTZ (Drug) $41.54
- CYLTEZO (Drug) $39.38
- TRINTELLIX (Drug) $32.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ashland
Mr. Stephen Perkey, Cnp, CNP
Family — Payments: $28,660
Ashley Malone, Msn, Rn, Fnp-Bc, MSN, RN, FNP-BC
Family — Payments: $9,852
Jessica Hicks, Aprn, APRN
Family — Payments: $9,119
Eva Joseph, Aprn, APRN
Family — Payments: $7,607
Brittany Linn
Family — Payments: $7,278
Ms. Brenda Sawyer, Lnp, LNP
Family — Payments: $6,342